Read more about the article A look at Oxervate and treatment for neurotrophic keratitis
Slit lamp photo of persistent epithelial defect (PED) in a patient with a history of zoster ophthalmicus; PED persisted despite placement of three amniotic membranes and autologous serum tears and eventually healed with Oxervate Source: Anat Galor, MD

A look at Oxervate and treatment for neurotrophic keratitis

There are a number of treatment strategies for neurotrophic keratopathy. Physicians discuss the different disease stages, management, and the FDA-approved medication available.

Comments Off on A look at Oxervate and treatment for neurotrophic keratitis

Ophthalmology at risk for significant cuts from 2021 E/M changes

All surgical specialties, particularly ophthalmology, are facing steep across-the-board cuts to reimbursement—through a reduction in the conversion factor—if the Centers for Medicare and Medicaid Services (CMS) 2021 policies for evaluation and management (E/M) go into effect without modification.

Comments Off on Ophthalmology at risk for significant cuts from 2021 E/M changes